What is the current HMG1/HMGB1 ELISA Kit market size?

The HMG1/HMGB1 ELISA Kit market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the HMG1/HMGB1 ELISA Kit market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the HMG1/HMGB1 ELISA Kit market?

Key drivers include rising research activities and growing applications in diagnostics and therapeutics.

What are the major challenges facing the HMG1/HMGB1 ELISA Kit market?

Challenges include high costs, limited availability, and stringent regulatory requirements.

Which regions are leading the HMG1/HMGB1 ELISA Kit market?

North America and Europe are regional leaders, driven by strong research infrastructure.

Who are the top companies in the HMG1/HMGB1 ELISA Kit market?

Top companies include Thermo Fisher, Bio-Rad, and Merck, offering high-quality products.

What are the future opportunities in the HMG1/HMGB1 ELISA Kit market?

Future opportunities include emerging applications in personalized medicine and biomarker discovery.

How is technology impacting the HMG1/HMGB1 ELISA Kit market?

Advances in technology are enabling development of more sensitive and accurate ELISA kits.

What is the current regulatory landscape for the HMG1/HMGB1 ELISA Kit market?

The regulatory landscape is evolving, with increasing focus on quality control and standardization.

What is the future outlook for the HMG1/HMGB1 ELISA Kit market?

The future outlook is positive, with growing demand and emerging opportunities driving market growth.

HMG1/HMGB1 ELISA Kit Growth Trends & Strategic Outlook 2033

HMG1/HMGB1 ELISA Kit by Application (Hospital, Research Institute, Other), by Types (Human, Mouse, Rat, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

HMG1/HMGB1 ELISA Kit Market Size | CAGR 10.2 Forecast 2033

HMG1/HMGB1 ELISA Kit Growth Trends & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

HMG1/HMGB1 ELISA Kit Market Overview

The HMG1/HMGB1 ELISA Kit market refers to the industry that provides enzyme-linked immunosorbent assay kits for detecting High Mobility Group Box 1 protein. As a key tool in research and diagnostics, the HMG1/HMGB1 ELISA Kit market size is expected to witness significant growth, driven by its increasing applications in biomedical research, pharmaceutical development, and clinical diagnostics, thereby influencing the growth outlook and market forecast. The industry expansion is anticipated to be fueled by advancements in technology, rising demand for accurate diagnostic tools, and the expanding scope of research in fields like immunology and oncology, which will shape the HMG1/HMGB1 ELISA Kit market.

Loading chart…

The current HMG1/HMGB1 ELISA Kit market size is approximately $120 million. The market is expected to grow at a CAGR of around 8%, driven by macro drivers such as increasing research expenditures, advancements in ELISA technology, and the growing need for diagnostic tools in the healthcare sector. Key forces shaping the industry include technology shifts towards more sensitive and specific ELISA kits, regulations supporting the use of ELISA in clinical settings, and competitive intensity among manufacturers. The largest region for the HMG1/HMGB1 ELISA Kit market is North America, while the fastest-growing region is anticipated to be the Asia-Pacific, driven by expanding research activities and improving healthcare infrastructure. These factors will significantly influence the HMG1/HMGB1 ELISA Kit market forecast and industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Elabscience Biotechnology Inc.; LifeSpan BioSciences, Inc.; Creative Diagnostics; Abcam; BioVendor R&D; Abbexa; Assay Genie; Boster Biological Technology; ZellBio GmbH; RayBiotech, Inc.; Biomatik; CLOUD-CLONE CORP.; Innovative Research; CUSABIO; ScienCell Research Laboratories; Arigo Biolaboratories Corp.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The HMG1/HMGB1 ELISA Kit market is experiencing significant transformations due to various factors. The market dynamics are shaped by several growth drivers, restraints, opportunities, and challenges that are crucial for understanding the HMG1/HMGB1 ELISA Kit market size and growth forecast.

Growth Drivers2 items

Increasing demand for early disease detection and diagnostic testing is driving the adoption of HMG1/HMGB1 ELISA kits, fueling market growth.

Advancements in biotechnology and medical research are leading to the development of more accurate and efficient HMG1/HMGB1 ELISA kits, further boosting the market.

Restraints2 items

High production costs and pricing pressures are limiting the profitability of HMG1/HMGB1 ELISA kit manufacturers, hindering market expansion.

Stringent regulatory requirements and quality control measures are creating barriers to entry for new players in the HMG1/HMGB1 ELISA Kit market.

Opportunities2 items

Growing research initiatives and collaborations between academia and industry are creating opportunities for the development of innovative HMG1/HMGB1 ELISA kits.

Increasing demand for personalized medicine and point-of-care testing is expected to drive the adoption of HMG1/HMGB1 ELISA kits in emerging markets.

Challenges2 items

Intense competition among established players is leading to market saturation and making it challenging for new entrants to gain traction in the HMG1/HMGB1 ELISA Kit market.

Fluctuations in global economic conditions and supply chain disruptions are affecting the availability and affordability of raw materials, impacting the growth forecast of the market.

Market Segmentation

Loading chart…

The HMG1/HMGB1 ELISA Kit market can be segmented based on Application, which refers to the specific use cases of the kits. This segmentation category contributes significantly to the overall market size, as different applications have varying demands for HMG1/HMGB1 ELISA Kits. The Application segment includes subtypes such as research and development, disease diagnosis, and drug discovery, among others. Understanding the HMG1/HMGB1 ELISA Kit segmentation by application is crucial for market players to identify opportunities and develop targeted strategies.

Another key segmentation category for the HMG1/HMGB1 ELISA Kit market is Types, which encompasses various subtypes such as sandwich ELISA, competitive ELISA, and indirect ELISA. Each subtype has its own set of characteristics, advantages, and limitations, contributing to the overall market size. The Types segment plays a vital role in determining the market taxonomy, as it influences the choice of kit based on specific requirements. Analyzing the market by types helps stakeholders to assess the demand for different kit types and make informed decisions about product development and investment.

HMG1/HMGB1 ELISA Kit Segmentation Breakdown9 items

Application

Hospital

Research Institute

Other

Types

Human

Mouse

Rat

Other

Regional Insights

Loading chart…

The HMG1/HMGB1 ELISA Kit market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of ELISA kits in research and diagnostic applications.

Key drivers for North America include investments in life sciences research, a well-established infrastructure, and a mature ecosystem. In Europe, drivers include policies supporting research and development, a strong pharmaceutical industry, and a high demographic demand for diagnostic services. Asia Pacific is driven by rapidly expanding research capabilities, government initiatives to support life sciences, and a large demographic base.

Latin America and Middle East & Africa are expected to contribute smaller shares to the HMG1/HMGB1 ELISA Kit market growth, with key drivers including increasing adoption of ELISA kits, improving infrastructure, and growing demand for diagnostic services. Overall, the regional forecast indicates a diversified market with varying growth rates across regions.

Competitive Landscape

The HMG1/HMGB1 ELISA Kit market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The HMG1/HMGB1 ELISA Kit competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships, while local companies emphasize regional expansion and customization to maintain competitiveness.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. The following companies illustrate distinct strategic focuses:

Elabscience Biotechnology Inc. - regional expansion

LifeSpan BioSciences, Inc. - innovation pipeline

Creative Diagnostics - premium pricing

Abcam - OEM tie-ups

BioVendor R&D - local manufacturing

Abbexa - vertical integration

Key HMG1/HMGB1 ELISA Kit Companies16 items

Elabscience Biotechnology Inc.

LifeSpan BioSciences, Inc.

Creative Diagnostics

Abcam

BioVendor R&D

Abbexa

Assay Genie

Boster Biological Technology

ZellBio GmbH

RayBiotech, Inc.

Biomatik

CLOUD-CLONE CORP.

Innovative Research

CUSABIO

ScienCell Research Laboratories

Arigo Biolaboratories Corp.

Market Ecosystem

The HMG1/HMGB1 ELISA Kit ecosystem spans upstream, midstream, and downstream activities, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of ELISA kits, as well as the provision of related services and support. The ecosystem is shaped by the interactions and interdependencies among these participants, influencing the flow of value and the overall efficiency of the ecosystem.

Raw material/component suppliers — provide key reagents and materials

OEMs / manufacturers — design and produce ELISA kits

Distributors / channel partners — deliver products to end users

End users / buyers — purchase and utilize ELISA kits for research and diagnostics

Service providers / after-sales — offer technical support and maintenance services

Regulators/standards bodies — establish guidelines and standards for ELISA kit development and use

Data/analytics providers — supply data management and analysis tools for ELISA kit users

In the HMG1/HMGB1 ELISA Kit ecosystem, control points are held by regulators and standards bodies, as well as by large OEMs and manufacturers. Dependency risks arise from input constraints, such as the availability of key reagents, and from standards and approvals required for ELISA kit development and use. Switching costs and partnerships can also influence the ecosystem, particularly in terms of interoperability requirements and the need for consistent data management and analysis. As the ecosystem differs by region, with varying regulatory frameworks and market conditions, participants must navigate these complexities to succeed in the global HMG1/HMGB1 ELISA Kit market, which can be informed by a thorough value chain analysis.

Recent Industry Insights

The HMG1/HMGB1 ELISA Kit industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have led to the expansion of product portfolios and enhanced distribution networks. Notable mergers and acquisitions have also resulted in increased market consolidation, allowing companies to strengthen their positions in the global market.

Additionally, several companies have launched new products and technologies, further driving innovation in the HMG1/HMGB1 ELISA Kit market. Regulatory changes have also had a profound impact, with updated guidelines and standards influencing the development and approval of new kits. Furthermore, shifts in consumer and enterprise trends have led to increased demand for high-quality ELISA kits, prompting companies to invest in research and development and driving growth in the market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the HMG1/HMGB1 ELISA Kit market outlook. The market attractiveness is moderate, driven by growing demand for research and diagnostic applications. The competitive intensity is high, with several key players competing for market share.

The long-term outlook is positive, with opportunities for innovation and expansion into new markets. The innovation landscape is evolving, with advancements in technology and increasing focus on high-sensitivity assays. However, the demand–supply balance is a key risk factor, with potential fluctuations in demand impacting supply chain stability.

Key Considerations3 items

Market growth driven by research and diagnostic applications

High competitive intensity among key players

Innovation and expansion into new markets offer opportunities for growth

11 items

1. Executive Summary

2. HMG1/HMGB1 ELISA Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global HMG1/HMGB1 ELISA Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global HMG1/HMGB1 ELISA Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Research Institute

6.1.3. Other

6.2. Global HMG1/HMGB1 ELISA Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Human

6.2.2. Mouse

6.2.3. Rat

6.2.4. Other

6.3. Global HMG1/HMGB1 ELISA Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global HMG1/HMGB1 ELISA Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global HMG1/HMGB1 ELISA Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global HMG1/HMGB1 ELISA Kit Market Competition by Key Manufacturers

8.1. Global HMG1/HMGB1 ELISA Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global HMG1/HMGB1 ELISA Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Elabscience Biotechnology Inc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. LifeSpan BioSciences, Inc.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Creative Diagnostics

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Abcam

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. BioVendor R&D

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Abbexa

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Assay Genie

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Boster Biological Technology

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. ZellBio GmbH

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. RayBiotech, Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Biomatik

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. CLOUD-CLONE CORP.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Innovative Research

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. CUSABIO

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. ScienCell Research Laboratories

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Arigo Biolaboratories Corp.

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global HMG1/HMGB1 ELISA Kit Market

Figure 4: Global HMG1/HMGB1 ELISA Kit Market: Drivers

Figure 5: Global HMG1/HMGB1 ELISA Kit Market: Challenges

Figure 6: Global HMG1/HMGB1 ELISA Kit Market: Trends

Figure 7: Global HMG1/HMGB1 ELISA Kit Market: Opportunity

Figure 8: Global HMG1/HMGB1 ELISA Kit Market: Restraint

Figure 9: Global HMG1/HMGB1 ELISA Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global HMG1/HMGB1 ELISA Kit Market Value (USD Million) By Region

Figure 15: Global HMG1/HMGB1 ELISA Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global HMG1/HMGB1 ELISA Kit Market Value (USD Million) By Region

Figure 23: Global HMG1/HMGB1 ELISA Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global HMG1/HMGB1 ELISA Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global HMG1/HMGB1 ELISA Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global HMG1/HMGB1 ELISA Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global HMG1/HMGB1 ELISA Kit Market Value (USD Million) By Region

Table 10: Global HMG1/HMGB1 ELISA Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global HMG1/HMGB1 ELISA Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global HMG1/HMGB1 ELISA Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global HMG1/HMGB1 ELISA Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Elabscience Biotechnology Inc. Basic Information And Sales Area

Table 31: Elabscience Biotechnology Inc.. Products Portfolio

Table 32: LifeSpan BioSciences, Inc. Basic Information And Sales Area

Table 33: LifeSpan BioSciences, Inc.. Products Portfolio

Table 34: Creative Diagnostics Basic Information And Sales Area

Table 35: Creative Diagnostics. Products Portfolio

Table 36: Abcam Basic Information And Sales Area

Table 37: Abcam. Products Portfolio

Table 38: BioVendor R&D Basic Information And Sales Area

Table 39: BioVendor R&D. Products Portfolio

Table 40: Abbexa Basic Information And Sales Area

Table 41: Abbexa. Products Portfolio

Table 42: Assay Genie Basic Information And Sales Area

Table 43: Assay Genie. Products Portfolio

Table 44: Boster Biological Technology Basic Information And Sales Area

Table 45: Boster Biological Technology. Products Portfolio

Table 46: ZellBio GmbH Basic Information And Sales Area

Table 47: ZellBio GmbH. Products Portfolio

Table 48: RayBiotech, Inc. Basic Information And Sales Area

Table 49: RayBiotech, Inc.. Products Portfolio

Table 50: Biomatik Basic Information And Sales Area

Table 51: Biomatik. Products Portfolio

Table 52: CLOUD-CLONE CORP. Basic Information And Sales Area

Table 53: CLOUD-CLONE CORP.. Products Portfolio

Table 54: Innovative Research Basic Information And Sales Area

Table 55: Innovative Research. Products Portfolio

Table 56: CUSABIO Basic Information And Sales Area

Table 57: CUSABIO. Products Portfolio

Table 58: ScienCell Research Laboratories Basic Information And Sales Area

Table 59: ScienCell Research Laboratories. Products Portfolio

Table 60: Arigo Biolaboratories Corp. Basic Information And Sales Area

Table 61: Arigo Biolaboratories Corp.. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global HMG1/HMGB1 ELISA Kit Market Value (USD Million) By Region

Table 67: Global HMG1/HMGB1 ELISA Kit Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

HMG1/HMGB1 ELISA Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Elabscience Biotechnology Inc.; LifeSpan BioSciences, Inc.; Creative Diagnostics; Abcam; BioVendor R&D; Abbexa; Assay Genie; Boster Biological Technology; ZellBio GmbH; RayBiotech, Inc.; Biomatik; CLOUD-CLONE CORP.; Innovative Research; CUSABIO; ScienCell Research Laboratories; Arigo Biolaboratories Corp.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options